Stock Movers
Stock Movers

Sep 7, 2026 · 7 min

Novartis stumbles as Nordex and European tech stocks rally

Stock Movers: Novartis, Soitec, Nordex (Podcast)

The episode contrasts drug-development risk with renewed confidence in wind power, semiconductors, AI, and smarter urban infrastructure.

3 key takeaways
  1. 1Novartis shares fell after two clinical-trial disappointments raised fresh concerns about its drug pipeline.
  2. 2Nordex gained after Bank of America cited stronger orders, potential earnings growth, and excessive recent underperformance.
  3. 3European technology stocks rallied on stronger photonics demand and optimism surrounding AI and semiconductor growth.

Don't miss

The clearest contrast comes as Novartis absorbs two clinical-trial disappointments while Nordex benefits from an analyst upgrade and stronger order expectations.

The brief

Caroline Hepburn and Chloe Melley open with a sharp split in European markets: Novartis is under pressure after two trial setbacks, while Nordex rallies after a Bank of America upgrade.

Novartis faced consecutive disappointments involving an experimental autoimmune-disease cell therapy and a heart drug that failed to reduce major cardiovascular events.

Nordex’s upgrade rests on potential earnings growth, stronger German and U.S. orders, a stable supply chain, and the view that recent share-price underperformance went too far.

Soitec and other European technology names rose with improved photonics demand and broader optimism around semiconductors and OpenAI’s GPT-6 Astra launch.

The episode then widens its lens to smart cities, asking how AI, infrastructure blueprints, and long-term planning can help urban systems absorb rapid population growth.

What was said on this episode

9 statements · 7 positive · 2 negative

  1. Chloe Melleyon Novartis drug pipelineNegative1:23

    Novartis needs to rebuild its drug-development pipeline

    “it really does need to grow that pipeline again”

    Listen at 1:23

  2. Chloe Melleyon Novartis DM1 drugPositive2:03

    The DM1 drug’s success will be crucial to Novartis’s outlook

    “the success of that drug will be key for the outlook”

    Listen at 2:03

  3. Chloe Melleyon Novartis sharesNegative2:06

    Another Novartis trial disappointment could sharply hurt its shares

    “another disappointment could, of course, weigh massively on the shares”

    Listen at 2:06

  4. Chloe Melleyon NordexPositive2:59

    Nordex is emerging from a difficult period for the wind industry

    “Nordex kind of emerging from a difficult period for the wind industry in general”

    Listen at 2:59

  5. Chloe Melleyon OpenAI's GPT-6 AstraPositive3:45

    GPT-6 Astra’s launch is driving current AI optimism

    “the main reason for this AI optimism today is the launch of OpenAI's GPT-6 Astra, this new model”

    Listen at 3:45

  6. Chloe Melleyon SwatekPositive4:28

    Swatek and peers benefit as suppliers to data centers and semiconductors

    “Swatek and those names that I mentioned are really benefiting from that as kind of key suppliers of those components of data centers and semiconductors and everything”

    Listen at 4:28

  7. Estefanía Tapiason AI in smart citiesPositive5:26

    AI will accelerate processes in smart-city systems

    “AI will allow in the smart city space to compress a lot of things. The speed will change.”

    Listen at 5:26

  8. Rohit Krishnanon DubaiPositive5:53

    Dubai responded effectively to its sudden population increase

    “they reacted very well to it”

    Listen at 5:53

  9. Rohit Krishnanon Dubai urban planningPositive5:54

    Dubai has a long-term urban-planning vision

    “They have a long-term urban planning vision”

    Listen at 5:54

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Books & mentions

Economy of Scale

Its smart-cities discussion extends the episode’s look at AI, infrastructure, and urban growth.

Listen to the full episode and explore every guest, topic, and moment on PodLume.

What is PodLume?

PodLume turns podcasts into searchable knowledge. AI-decoded transcripts, identified guests and topics, smart highlights, and cross-show search across the world’s best conversations — all in your pocket.

Novartis stumbles as Nordex and European tech stocks rally | PodLume